| (-)-3,4-Dihydroxynorephedrine Basic information |
| (-)-3,4-Dihydroxynorephedrine Chemical Properties |
Melting point | 212-215°C dec. | alpha | D25 -31.0° (c = 0.5 in 0.01N HCl) | Boiling point | 431.6±40.0 °C(Predicted) | density | 1.328±0.06 g/cm3(Predicted) | storage temp. | −20°C | solubility | DMSO: soluble5mg/mL, clear (warmed) | pka | 9.59±0.10(Predicted) | form | powder | color | white to light brown | Merck | 13,6725 |
Hazard Codes | Xn | Risk Statements | 20/21/22-36/37/38 | Safety Statements | 26-36 | RIDADR | UN 2811 6.1 / PGII | WGK Germany | 3 | HS Code | 2922504500 | Toxicity | LD50 in mice (mg/kg): 12.6 i.v. (Luduena) |
| (-)-3,4-Dihydroxynorephedrine Usage And Synthesis |
Chemical Properties | White Powder | Uses | A vasoconstrictor which also increases the potency and duration of anesthesia produced by local anesthetics | Uses | Vasoconstrictor;Adrenergic receptor agonist | Definition | ChEBI: Alpha-methylnoradrenaline is a catecholamine in which the 2-aminoethyl group is substituted with a hydroxy group at C-1 and a methyl group at C-2, with configurations 1R,2S. A metabolite of alpha-methyl-L-dopa, it is an alpha2-adrenergic agonist and acts as a topical nasal decongestant and vasoconstrictor, most often used in dentistry. It has a role as an alpha-adrenergic agonist, a vasoconstrictor agent and a nasal decongestant. | Brand name | Neo-Cobefrin (Cook-Waite). |
| (-)-3,4-Dihydroxynorephedrine Preparation Products And Raw materials |
|